Quali sono gli orari di apertura?

Lunedì 08:30 - 18:30 Martedì 08:30 - 18:30 Mercoledì 08:30 - 18:30 Giovedì 08:30 - 18:30 Venerdì 08:30 - 18:30 Sabato 08:30 - 12:30

European Association of Urology

Casa
Italia
Rome
European Association of Urology

Informazioni di contatto, mappa e indicazioni stradali, modulo di contatto, orari di apertura, servizi, valutazioni, foto, video e annunci di European Association of Urology, Medicina e salute, Italia Via Alvaro del Portillo, 200, Rome.

European Association of Urology
Sede italiana: Roma
Centro di eccellenza per la salute maschile
Prostatite, iperplasia, disturbi della potenza
Da 20 anni al servizio dell'uomo

14/02/2026

🩺 5 abitudini quotidiane per la salute maschile dopo i 40 anni

Dopo i 40 anni, il corpo cambia. E anche le attenzioni devono cambiare.

Ecco 5 semplici abitudini che ogni uomo dovrebbe seguire per stare bene più a lungo:

✅ 1. Bere almeno 1,5 litri d'acqua al giorno
Aiuta i reni, la prostata e la circolazione.

✅ 2. Limitare alcol e cibi grassi
Soprattutto la sera. Il fegato e la prostata ti ringrazieranno.

✅ 3. Fare movimento ogni giorno
Anche 30 minuti di camminata veloce riducono il rischio di infiammazioni.

✅ 4. Controlli regolari
Dopo i 40, una visita urologica all'anno dovrebbe essere normale.

✅ 5. Ascoltare il proprio corpo
Bruciore? Minzione frequente? Stanchezza? Non ignorare i segnali.

👇 Quale di queste abitudini segui già? Scrivilo nei commenti.

14/02/2026

🔍 Mito o realtà? Scopri la verità sulla prostatite.

🧠 “La prostatite è solo un problema degli anziani.”

❌ FALSO.

La realtà è che la prostatite colpisce uomini di tutte le età, soprattutto tra i 30 e i 50 anni.

Spesso viene confusa con altre infiammazioni o trascurata per imbarazzo. Ma ignorare i sintomi può portare a complicazioni serie nel tempo.

✅ I sintomi più comuni:
Minzione frequente (soprattutto di notte)

Dolore o bruciore durante la minzione

Difficoltà a urinare

Sensazione di svuotamento incompleto

Dolore nella zona pelvica o lombare

🩺 Cosa fare?
Non aspettare che passi da solo.

Parla con uno specialista.

Informati sulle soluzioni naturali e mediche.

La diagnosi precoce fa la differenza.

👇 Hai mai avuto uno di questi sintomi? Scrivi nei commenti.

14/02/2026

In Italia, 1 uomo su 2 oltre i 50 anni soffre di iperplasia prostatica.
Eppure, il 70% non ne parla con un medico.
Noi siamo qui per questo. Da 20 anni.

14/02/2026

I primi segnali di problemi alla prostata:
🔹 Minzione frequente (soprattutto di notte)
🔹 Dolore o bruciore
🔹 Sensazione di svuotamento incompleto
Se hai +40, non ignorarli. La prevenzione è tutto.

17/10/2024

1 Introduction
Prostatitis (i.e. chronic pelvic pain syndrome [CPPS]) is a disabling condition affecting 10–14% of men of all ages and ethnic origins [1,2]. Up to 50% of men at some point in their lives suffer from this condition [3]. As early as 1980, the National Ambulatory Medical Care Survey reported 20 office visits per 1000 men per year for symptoms compatible with prostatitis [4]. Data from the National Center for Health Statistics showed that in the USA in 1985 there were actually more physician visits for prostatitis than for benign prostatic hyperplasia or prostate cancer [5]. Because of the significant impact of CPPS, considerable attention has been directed to elucidating its epidemiology and demographics.

17/10/2024

2 Epidemiology
The epidemiology of prostatitis is concerned with understanding the distribution and determinants of the condition. To discuss the epidemiology of prostatitis, a definition is essential. However, the task of defining prostatitis has been confounded by the fact that there are several types of “prostatitis” (bacterial and nonbacterial), each with different characteristics and treatments. The common term “prostatitis” has traditionally been used both in practice and in literature to cover all of these conditions.

17/10/2024

3 Definition
The traditional classification of “prostatitis” included acute and chronic bacterial prostatitis, which affect less than 5% of men with prostatitis and for which treatment and management are usually successful [3,6]. The majority of patients with prostatitis were traditionally judged to have either nonbacterial prostatitis or prostatodynia. Both of these conditions are characterized by pelvic pain, but only the former is associated with inflammatory cells in the prostatic fluid.
In 1995, a workshop on chronic prostatitis convened by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the US National Institutes of Health (NIH) created a new working definition and classification of prostatitis syndromes as follows [7].
(I)
Acute bacterial prostatitis, acute infection of the prostate.
(II)
Chronic bacterial prostatitis, recurrent infection of the prostate.
(III)
Chronic nonbacterial prostatitis/chronic pelvic pain syndrome (CP/CPPS), where there is no demonstrable infection. Subgroups of this class are:
(A)
Inflammatory chronic pelvic pain syndrome, where leukocytes are found in the expressed prostatic secretions (EPS), urine obtained after prostate massage (voided bladder urine-3 [VB-3]), or semen.
(B)
Non-inflammatory chronic pelvic pain syndrome, where no evidence of inflammation is found in the EPS, VB-3, or semen.
(IV)
Asymptomatic inflammatory prostatitis (AIP), where there are no subjective symptoms, but white blood cells are found in prostate secretions or in prostate tissue during an evaluation for other disorders.
Unlike patients in categories I and II, patients with category III prostatitis do not have any detectable colonization or infection of the prostate, as determined by conventional microbiological techniques; abnormalities in the EPS are the primary objective feature of category III prostatitis. Chronic pain is the primary subjective symptom. The majority of patients with “prostatitis” are in category III [4].

17/10/2024

4 Prevalence and incidence
The most commonly used measures of disease occurrence (or frequency) in epidemiology are prevalence and incidence. The prevalence of prostatitis refers to the proportion of people who have prostatitis at a specific instance in time. In contrast, the incidence of prostatitis refers to the rate of occurrence of new cases. Of the almost 13 million visits to US urologists in 1991, 5.3% were reported to be for inflammatory diseases of the prostate [8]. A community-based cohort study in Minnesota by Roberts utilized data from the Olmstead County study of urinary symptoms and health status among men [9]. In 1992–1996, they found the overall prevalence of physicians’ diagnoses of prostatitis was 11%. In a survey of younger men from the Wisconsin National Guard, Moon et al. found that 5% of respondents reported a history of prostatitis [10]. In a Canadian study, Nickel et al. surveyed 5000 primary care physicians and 545 urologists regarding their practice patterns and this condition and estimated the prevalence to be 9.7% [2]. Among men with a previous diagnosis of prostatitis, the cumulative incidence (the proportion of men without prostatitis in a population who develop the condition over a specified period of time) of subsequent episodes of prostatitis was much higher: 20%, 38%, and 50% among men aged 40, 60, and 80 years, respectively. Few published data are available for the epidemiology of prostatitis outside North America. A population-based study in northern Finland found a high overall lifetime prevalence of prostatitis of 14.2%; of those reporting current or past episodes of prostatitis, 27% experienced symptoms at least once a year, while 16% suffered from persistent symptoms [1].

17/10/2024

5 The Chronic Prostatitis Cohort Study: demographics and baseline analysis
The NIDDK funded the Chronic Prostatitis Collaborative Research Network (CPCRN) in 1997 to conduct basic and clinical research in CPPS. The CPCRN developed a prospective longitudinal Chronic Prostatitis Cohort (CPC) Study and also coordinated the development and validation of a symptom severity index, the Chronic Prostatitis Symptom Index. This index, known as the NIH-CPSI, is an integral component of the symptom measurements within the CPC Study [11]. Data from the baseline analysis of the cohort study have been published.

5.1 Methods
Patient accrual for the CPC Study began on 16 October 1998. All 488 patients who had been successfully screened and enrolled into the CPC cohort prior to closing recruitment on 22 August 2001, were selected for this statistical analysis. The NIH-CPSI, including subscores, was used to measure symptoms. A comprehensive history, physical examination, and demographic profile were obtained from each participant. Generalized Mantel–Haenszel procedures were used to investigate baseline associations between selected factors and symptoms.

5.2 Age
The 488 men in the cohort study had a mean age of 42.8 years (range 30–83 years) and a mean duration of chronic prostatitis of 6.9 years (Table 1). Utilizing case control studies, Berber et al. [14] revealed that cases (n=34) compared to controls (n=50) were more often older (mean age 40 versus 33). A study of the National Ambulatory Medical Care Survey (NAMCS) 1990–1994 revealed that compared to men age 66 and older, prostatitis was more commonly diagnosed in men 36–65 years of age than in men 18–35 years of age. Thus, there appears to be a slight increase in the diagnosis of prostatitis with age.

Indirizzo

Italia Via Alvaro Del Portillo, 200
Rome
00128

Orario di apertura

Lunedì	08:30 - 18:30
Martedì	08:30 - 18:30
Mercoledì	08:30 - 18:30
Giovedì	08:30 - 18:30
Venerdì	08:30 - 18:30
Sabato	08:30 - 12:30

Sito Web

https://www.policlinicocampusbiomedico.it/

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando European Association of Urology pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.